Kennedy-Enzi Hearing


The witness roster for the peculiarly timed Senate Committee on Health, Education, Labor and Pensions entitled "Building a 21st Century FDA:  Proposals to Improve Drug Safety and Innovation" has been filled.  The hearing will occur November 16, Thursday at 10 AM in Room 430 of the Dirksen Senate Office Building. 

Panel I

  • Ms. Sheila Burke, co-Chair, Committee on the Assessment of the U.S. Drug Safety System, Institute of Medicine, Washington, D.C.

Panel II

  • Ms. Diane Thompson, Vice President, Public Policy and Communications, Elizabeth Glaser Pediatric AIDS Foundation, Washington, D.C.
  • Dr. Steven Nissen, Chairman, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio
  • Dr. Adrian Thomas, Vice President, Benefit-Risk Management, Johnson & Johnson Pharmaceutical Group, Horsham, PA
  • Mr. Jim Guest, President & CEO, Consumers Union, Yonkers, New York
  • Mr. Greg Simon, President, FasterCures, Washington, D.C.

Note that Dr. Steven Nissen, an FDA Advisory Committee member, was a key figure in assessing risk associated with COX-2s during the special advisory committee meetings held in relation to that class of drugs. 

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter
This entry was posted in Current Affairs. Bookmark the permalink.